Efficacy of upadacitinib for moderate-to-severe atopic dermatitis: analysis of time spent in skin clearance response states from the Measure Up 1, Measure Up 2 and Heads Up studies

被引：0
|
作者：
Blauvelt, Andrew [1 ]
Silverberg, Jonathan, I [2 ]
Calimlim, Brian M. [3 ]
Liu, Yingyi [3 ]
Platt, Andrew [3 ]
Thyssen, Jacob P. [4 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA
[3] AbbVie Inc, N Chicago, IL USA
[4] Bispebjerg Hosp, Dept Dermatol, Copenhagen, Denmark
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
upadacitinib; dupilumab; atopic dermatitis; skin clearance; EASI;
D O I：
10.1093/bjd/ljac140.047
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
355
引用
收藏
页数：2
相关论文
共 50 条
  • [1] The effect of upadacitinib on the genital region in moderate-to-severe atopic dermatitis: an analysis from the Measure Up 1 and Measure Up 2 studies
    Cather, Jennifer
    Magnolo, Nina
    Cameron, Michael
    Calimlim, Brian
    Lane, Michael
    Hays, Stephanie
    Gamelli, Amy
    Woo, Yu Ri
    BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [2] Upadacitinib in moderate-to-severe atopic dermatitis: combined safety analysis of phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Guttman-Yassky, Emma
    Irvine, A. D.
    Silverberg, J. I.
    Papp, K. A.
    Paller, A. S.
    Waterhouse, B.
    Tenorio, A. R.
    Ladizinski, B.
    Chu, A. D.
    Liu, J.
    Reich, Kristian
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E123 - E124
  • [3] Upadacitinib in moderate-to-severe atopic dermatitis: Combined safety analysis of phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)
    Guttman-Yassky, Emma
    Irvine, Alan D.
    Silverberg, Jonathan I.
    Papp, Kim A.
    Paller, Amy S.
    Waterhouse, Brian
    Tenorio, Allan R.
    Ladizinski, Barry
    Chu, Alvina D.
    Liu, John
    Reich, Kristian
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB129 - AB129
  • [4] Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical Trials
    Paller, Amy S.
    Ladizinski, Barry
    Mendes-Bastos, Pedro
    Siegfried, Elaine
    Soong, Weily
    Prajapati, Vimal H.
    Lio, Peter
    Thyssen, Jacob P.
    Simpson, Eric L.
    Platt, Andrew M.
    Raymundo, Eliza M.
    Liu, Jianzhong
    Calimlim, Brian M.
    Huang, Xiaohong
    Gu, Yihua
    Hu, Xiaofei
    Yang, Yang
    Su, John C.
    Zheng, Min
    Yamamoto-Hanada, Kiwako
    Teixeira, Henrique D.
    Irvine, Alan D.
    JAMA DERMATOLOGY, 2023, 159 (05) : 526 - 535
  • [5] Efficacy of upadacitinib vs dupilumab for moderate-to-severe atopic dermatitis: analysis of time spent in itch response state from the Heads Up study
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein
    Kwatra, Shawn G.
    Gooderham, Melinda J.
    Kim, Brian
    Liu, Yingyi
    Chu, Alvina D.
    Ofori, Sarah
    Platt, Andrew
    Calimlim, Brian M.
    Silverberg, Jonathan, I
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 190 : II28 - II29
  • [6] EFFICACY OF UPADACITINIB VS DUPILUMAB FOR MODERATE-TO-SEVERE ATOPIC DERMATITIS: ANALYSIS OF TIME SPENT IN ITCH RESPONSE STATE FROM THE HEADS UP STUDY
    Blauvelt, Andrew
    de Bruin-Weller, Marjolein S.
    Kwatra, Shawn G.
    Gooderham, Melinda J.
    Kim, Brian
    Liu, Yingyi
    Chu, Alvina
    Oforia, Sarah
    Platt, Andrew
    Calimlim, Brian
    Silverberg, Jonathan I.
    ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 21 - 21
  • [7] Efficacy and safety of upadacitinib in adults and adolescents with moderate-to-severe atopic dermatitis: a subgroup analysis of the Measure Up 1, Measure Up 2 and AD Up phase III clinical trials
    Paller, A. S.
    Mendes-Bastos, P.
    Eichenfield, L. F.
    Soong, W.
    Lio, P.
    Prajapati, V. H.
    Platt, A. M.
    Teixeira, H. D.
    Liu, J.
    Ladizinski, B.
    Thyssen, J. P.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E128 - E129
  • [8] Rapid skin improvement with upadacitinib with or without topical corticosteroids in moderate-to-severe atopic dermatitis: results from three phase III studies (Measure Up 1, Measure Up 2 and AD Up)
    Simpson, E. L.
    Warren, R. B.
    Eichenfield, L. F.
    Katoh, N.
    Hu, X.
    Zeng, J.
    Calimlim, B. M.
    Tenorio, A. R.
    Teixeira, H. D.
    De Bruin-Weller, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E118 - E119
  • [9] Achieving incrementally greater skin improvement thresholds with upadacitinib in moderate-to-severe atopic dermatitis: a pooled analysis of two phase III studies (Measure Up 1 and Measure Up 2)
    Reich, K.
    Langley, R. G.
    Calimlim, B. M.
    Teixeira, H. D.
    Zeng, J.
    Silverberg, J. I.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E131 - E132
  • [10] Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis Analysis of Follow-up Data From the Measure Up 1 and Measure Up 2 Randomized Clinical Trials
    Simpson, Eric L.
    Papp, Kim A.
    Blauvelt, Andrew
    Chu, Chia-Yu
    Hong, H. Chih-Ho
    Katoh, Norito
    Calimlim, Brian M.
    Thyssen, Jacob P.
    Chiou, Albert S.
    Bissonnette, Robert
    Gold, Linda F. Stein
    Wegzyn, Colleen
    Hu, Xiaofei
    Liu, Meng
    Liu, John
    Tenorio, Allan R.
    Chu, Alvina D.
    Guttman-Yassky, Emma
    JAMA DERMATOLOGY, 2022, 158 (04) : 404 - 413
12345